ResearcherUniversity of CambridgeActive in the last 2 years
Siong‐Seng Liau
Matched on ORCID iD 0000-0001-5155-4300; OpenAlex author ID A5088409317. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 3
2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 2 papers
Papers 3
- Retraction: HMGA1 Is a Determinant of Cellular Invasiveness and In vivo Metastatic Potential in Pancreatic Adenocarcinoma. Co-author DOI 10.1158/0008-5472.can-25-0888↗
- Editor's Note: HMGA1 Is a Molecular Determinant of Chemoresistance to Gemcitabine in Pancreatic Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-25-0819↗
- Chromosome instability and carcinogenesis: insights from murine models of human pancreatic cancer associated with BRCA2 inactivation. First author DOI 10.1016/j.molonc.2013.10.005↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Edward E. Whang · 2 shared papers, 2025 · strength 0.96
- Paper Editor's Note: HMGA1 Is a Molecular Determinant of Chemoresistance to Gemcitabine in Pancreatic Adenocarcinoma. DOI 10.1158/1078-0432.ccr-25-0819↗
- Paper Retraction: HMGA1 Is a Determinant of Cellular Invasiveness and In vivo Metastatic Potential in Pancreatic Adenocarcino… DOI 10.1158/0008-5472.can-25-0888↗
- Ashok R. Venkitaraman · 1 shared paper, 2014 · strength 0.07
- Liam D. Cassidy · 1 shared paper, 2014 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.